Australian shares end higher as Omicron fears ease; post third monthly loss

* Collins Foods top gainer on ASX200

* Miners lead gains on the local bourse

* NZX 50 rises 1.5% (Updates to close)

By Riya Sharma

Nov 30 (Reuters) - Australian shares closed higher on Tuesday as concerns about the Omicron coronavirus variant eased further, although the benchmark index posted a third straight monthly loss.

The S&P/ASX 200 index .AXJO ended 0.22% higher at 7,256, after climbing 1% in early trade — the biggest since early-October​. For the month, the benchmark shed 0.9%.

Travel stocks rebounded after two days of heavy selling, as hopes that the new variant might be milder than initially feared boosted investor sentiment.

Airline operator Qantas Airways QAN.AX climbed 4.1% to mark its best day in over three weeks, while online travel websites Flight Centre Travel Group FLT.AX and Webjet WEB.AX jumped 6.7% and 6.2%, respectively.

"Investors have kept aside concerns over the impact of the new coronavirus variant on the economic recovery and are cautiously optimistic while waiting for more details on Omicron," said Kunal Sawhney, CEO of Kalkine Group said.

The country's economy also showed signs of strength, with Australia's current account surplus increasing A$1 billion in the September quarter to a record A$23.9 billion ($16.98 billion), thanks to iron ore and coal prices.

"Robust prices for exports of coal and other mineral fuels helped the nation observe a record surplus, however, the road ahead to economic revival seems bumpy as the new variant heightens concerns around global growth," said Sawhney.

Fast-food chain operator Collins Foods CKF.AX led gains on the local bourse, rising 13.8% to a record high after reporting upbeat first-half results.

Major miners .AXMM rose 0.27% as Chinese iron ore futures extended their rally, with BHP Group BHP.AX jumping 2.1% to its highest in more than two months.

Lithium miner Orocobre ORE.AX scaled 9.7% to a record high after a production upgrade at its annual general meeting.

New Zealand's benchmark S&P/NZX 50 index .NZ50 rose 1.5% to finish at 12,718.9. ($1 = 1.4077 Australian dollars)
Reporting by Riya Sharma in Bengaluru; editing by Uttaresh.V

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.